Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, January – September 2021
Jostein Starrfelt, Eirik Alnes Buanes, Lene Kristine Juvet, Trude Marie Lyngstad, Gunnar Øyvind Isaksson Rø, Lamprini Veneti, Hinta Meijerink
doi: https://doi.org/10.1101/2021.11.12.21266222
Jostein Starrfelt
1Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway
Eirik Alnes Buanes
2Norwegian Intensive Care and Pandemic Registry (NIPaR), Helse Bergen Health Trust, Bergen, Norway
3Department of Anaesthesiology and Intensive Care Haukeland University Hospital, Bergen, Norway
Lene Kristine Juvet
4Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
5Department of Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway
Trude Marie Lyngstad
1Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway
Gunnar Øyvind Isaksson Rø
5Department of Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway
Lamprini Veneti
1Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway
Hinta Meijerink
4Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
Data Availability
Legal restrictions prevent sharing the dataset used in this study. However, researchers are able to request access to linked data from the same registries, as per normal procedure for conducting health research on registry data in Norway. Further information on the preparedness registry, including access to data from each data source, is available at https://www.fhi.no/en/id/infectiousdiseases/coronavirus/emergency-preparedness-register-for-covid-19/
Posted November 12, 2021.
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, January – September 2021
Jostein Starrfelt, Eirik Alnes Buanes, Lene Kristine Juvet, Trude Marie Lyngstad, Gunnar Øyvind Isaksson Rø, Lamprini Veneti, Hinta Meijerink
medRxiv 2021.11.12.21266222; doi: https://doi.org/10.1101/2021.11.12.21266222
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, January – September 2021
Jostein Starrfelt, Eirik Alnes Buanes, Lene Kristine Juvet, Trude Marie Lyngstad, Gunnar Øyvind Isaksson Rø, Lamprini Veneti, Hinta Meijerink
medRxiv 2021.11.12.21266222; doi: https://doi.org/10.1101/2021.11.12.21266222
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)